Communication Challenges During the Development and Introduction of a New Meningococcal Vaccine in Africa

被引:17
|
作者
Berlier, Monique [1 ]
Barry, Rodrigue [2 ]
Shadid, John [3 ]
Sirica, Coimbra [4 ]
Brunier, Alison [5 ]
Hasan, Hayatee [6 ]
Bouma, Enricke [1 ]
机构
[1] PATH, Meningitis Vaccine Project, Ferney Voltaire, France
[2] WHO, Intercountry Support Team West Africa, Ouagadougou, Burkina Faso
[3] UN Childrens Fund, West & Cent Africa Reg Off, Dakar, Senegal
[4] Burness Commun, Bethesda, MD USA
[5] WHO, Dept Commun Capac Bldg, CH-1211 Geneva, Switzerland
[6] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland
关键词
advocacy and communication; messaging; vaccine introduction; meningitis belt; crisis communication; CONJUGATE VACCINE; MENINGITIS; TEMPERATURE; BENEFITS; CHAD;
D O I
10.1093/cid/civ493
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. A new group A meningococcal conjugate vaccine was developed to eliminate deadly meningitis epidemics in sub-Saharan Africa. Methods. From the outset of the project, advocacy and communication strategies were developed and adjusted as the project evolved in Europe, Africa, India, and the United States. Communications efforts were evidence-based, and involved partnerships with the media and various stakeholders including African ministries of health, the World Health Organization, UNICEF, Gavi, the Centers for Disease Control and Prevention, and M,decins Sans FrontiSres. Results. The implementation of an integrated communication strategy ensured the active cooperation of stakeholders while providing an organized and defined format for the dissemination of project-related developmental activities and the successful introduction of the vaccine. Conclusions. Early in the project, a communications strategy that engaged stakeholders and potential supporters was developed. The strategy was implemented and adapted as the project matured. Linked communication proved to be key to the successful wide-scale introduction of the PsA-TT (MenAfriVac) vaccine in Africa.
引用
收藏
页码:S451 / S458
页数:8
相关论文
共 50 条
  • [1] Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa
    Okoko, Brown J.
    Idoko, Olubukola T.
    Adegbola, Richard A.
    VACCINE, 2009, 27 (14) : 2023 - 2029
  • [2] Meningococcal meningitis epidemics in sub-Saharan Africa and the meningococcal A conjugate vaccine
    Nicolas, P.
    MEDECINE ET SANTE TROPICALES, 2012, 22 (03): : 246 - 258
  • [3] Successful African introduction of a new Group A meningococcal conjugate vaccine: Future challenges and next steps
    LaForce, F. Marc
    Djingarey, Mamoudou
    Viviani, Simonetta
    Preziosi, Marie-Pierre
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (05) : 1098 - 1102
  • [4] Vaccine prevention of meningococcal disease in Africa: Major advances, remaining challenges
    Mustapha, Mustapha M.
    Harrison, Lee H.
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2018, 14 (05) : 1107 - 1115
  • [5] Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience
    Djingarey, Mamoudou H.
    Barry, Rodrigue
    Bonkoungou, Mete
    Tiendrebeogo, Sylvestre
    Sebgo, Rene
    Kandolo, Denis
    Lingani, Clement
    Preziosi, Marie-Pierre
    Zuber, Patrick L. F.
    Perea, William
    Hugonnet, Stephane
    Tolve, Nora Dellepiane de Rey
    Tevi-Benissan, Carole
    Clark, Thomas A.
    Mayer, Leonard W.
    Novak, Ryan
    Messonier, Nancy E.
    Berlier, Monique
    Toboe, Desire
    Nshimirimana, Deo
    Mihigo, Richard
    Aguado, Teresa
    Diomande, Fabien
    Kristiansen, Paul A.
    Caugant, Dominique A.
    LaForce, F. Marc
    VACCINE, 2012, 30 : B40 - B45
  • [6] Technical Development of a New Meningococcal Conjugate Vaccine
    Frasch, Carl E.
    Kapre, Subhash V.
    Lee, Che-Hung
    Preaud, Jean-Marie
    CLINICAL INFECTIOUS DISEASES, 2015, 61 : S404 - S409
  • [7] Risk Assessment and Meningococcal A Conjugate Vaccine Introduction in Africa: The District Prioritization Tool
    Cibrelus, Laurence
    Lingani, Clement
    Fernandez, Katya
    Djingarey, Mamoudou H.
    Perea, William A.
    Hugonnet, Stephane
    CLINICAL INFECTIOUS DISEASES, 2015, 61 : S442 - S450
  • [8] Eliminating Epidemic Group A Meningococcal Meningitis In Africa Through A New Vaccine
    LaForce, F. Marc
    Okwo-Bele, Jean-Marie
    HEALTH AFFAIRS, 2011, 30 (06) : 1049 - 1057
  • [9] Meningococcal vaccine A new vaccine to combat meningococcal disease in India
    Verma, Ramesh
    Khanna, Pardeep
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (12) : 1904 - 1906
  • [10] Development of a group A meningococcal conjugate vaccine, MenAfriVac™
    Frasch, Carl E.
    Preziosi, Marie-Pierre
    LaForce, F. Marc
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2012, 8 (06) : 715 - 724